Broad-Spectrum Kinase Binding Agents for Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current protein kinase binding agents lack broad specificity, limiting their effectiveness in cellular kinase profiling and purification, and there is a need for improved methods to detect and quantify kinases across various cellular pathways.
Innovation Solution
Development of broad-spectrum protein kinase binding agents, such as CC-1852, CC-1861, and CTx-0294885, which are attached to functional elements or solid surfaces, enabling detection and quantification of kinases using detectable tracers and various analytical techniques like fluorescence and mass spectrometry.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional protein kinase binding agents are used, then kinase detection is possible, but specificity and sensitivity are insufficient for broad-spectrum kinase profiling
Solution Approach 1:
The patent applies universality by designing a single binding agent structure (Formula I) that can bind to multiple different protein kinases simultaneously. The core structure features a hydrophobic pocket that accommodates various kinase ATP-binding sites, allowing one agent to serve multiple detection functions across different kinase families including serine/threonine and tyrosine kinases.
Solution Approach 2:
The patent employs parameter changes by modifying specific substituents in Formula I (such as R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16, R17, R18, R19, R20, R21, R22, R23, R24, R25, R26, R27, R28, R29, R30, R31, R32, R33, R34, R35, R36, R37, R38, R39, R40, R41, R42, R43, R44, R45, R46, R47, R48, R49, R50, R51, R52, R53, R54, R55, R56, R57, R58, R59, R60, R61, R62, R63, R64, R65, R66, R67, R68, R69, R70, R71, R72, R73, R74, R75, R76, R77, R78, R79, R80, R81, R82, R83, R84, R85, R86, R87, R88, R89, R90, R91, R92, R93, R94, R95, R96, R97, R98, R99, R100) to optimize binding affinity and selectivity for different kinase targets while maintaining the core broad-spectrum binding capability.
2Measurement precision
If kinase binding agents with high specificity are developed, then detection accuracy improves, but the complexity of the agent structure increases
Solution Approach 1:
The patent applies segmentation by dividing the binding agent into distinct functional modules: a core hydrophobic pocket structure that provides broad kinase binding capability, and variable substituent groups (R1-R100) that can be independently optimized for specific kinase targets. This modular approach allows systematic enhancement of specificity without overwhelming structural complexity.
Solution Approach 2:
The patent employs composite material principles by combining the core binding scaffold with various functional substituents that provide different properties such as hydrophobic interactions, hydrogen bonding, and electrostatic interactions. This composite structure enables high specificity through multiple simultaneous interactions with the kinase target.
3Adaptability or versatility
If broad-spectrum kinase binding agents are used for cellular profiling, then kinase coverage is improved, but detection sensitivity decreases
Solution Approach 1:
The patent applies local quality by maintaining a conserved core binding region that provides broad kinase recognition while allowing localized variations in the substituent groups (R1-R100) to enhance binding affinity for specific kinase subfamilies. This enables the agent to adapt its binding characteristics locally for different targets while maintaining overall broad-spectrum capability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These agents provide enhanced specificity and sensitivity in detecting and quantifying kinases, allowing for effective profiling, purification, and monitoring of kinase interactions, thereby improving our understanding of kinase-related diseases and therapeutic responses.
Implementation Method 1
broad-spectrum protein kinase binding agents, such as CC-1852, CC-1861, and CTx-0294885, which are attached to functional elements or solid surfaces, enabling detection and quantification of kinases
Implementation Method 2
detection and quantification of kinases using detectable tracers and various analytical techniques like fluorescence and mass spectrometry
Data Source
AI summary
Provided herein are compounds that are broad-spectrum protein kinase binding agents, detectable tracers comprising such compounds, and method of use thereof for the detection of protein kinases.